| Old Articles: <Older 54911-54920 Newer> |
|---|
 |
The Motley Fool
January 10, 2012
John Grgurich |
Netflix Takes the Fight to Amazon Netflix crosses the pond in an audacious bid to turn its fortunes around.   |
The Motley Fool
January 10, 2012
Sean Williams |
Idenix Pharmaceuticals Shares Skyrocketed Again: What You Need to Know Shares of hepatitis-C drug hopeful Idenix Pharmaceuticals are continuing their rally for a second day, currently up 21%, as speculation swirls that it will be the next takeover candidate. |
The Motley Fool
January 10, 2012
Evan Niu |
18 More Reasons to Love This Rule Breaker MAKO Surgical keeps on keeping on. |
The Motley Fool
January 10, 2012
Alyce Lomax |
What's Really Killing Best Buy? The short answer: a toxic cocktail. Investors, beware. |
The Motley Fool
January 10, 2012
Selena Maranjian |
Make Money in Steady, Growing Stocks the Easy Way These low-volatility companies have been good growers. |
The Motley Fool
January 10, 2012
Patrick Martin |
I Will Not Touch That Hot IPO in 2012 Let's revisit my biggest investing mistakes of 2011. |
The Motley Fool
January 10, 2012
John Rosevear |
A Better Idea Than the Dogs of the Dow The "Dogs of the Dow" strategy has had its day -- but its basic idea is sound. |
The Motley Fool
January 10, 2012
Tamara Rutter |
I Will Not Buy Into the Hype in 2012 How to limit the risk of IPO investments. |
The Motley Fool
January 10, 2012
Brian Orelli |
Linear Growth Isn't Enough Human Genome Sciences needs to accelerate growth. |
The Motley Fool
January 10, 2012
Travis Hoium |
Regeneron Pharmaceuticals Shares Jumped: What You Need to Know Shares of Regeneron Pharmaceuticals jumped 13% today after the company said sales of Eylea were strong in the fourth quarter. |
| <Older 54911-54920 Newer> Return to current articles. |
